Assessment of Acute Myeloid Leukemia for Expression of Tryptase and CD123 by Immunohistochemistry

被引：0
|
作者：
Hatooglu, Medina [1 ]
O'Malley, Dennis [2 ]
机构：
[1] NeoGen Labs Inc, Aliso Viejo, CA USA
[2] NeoGen Labs Inc, Dana Point, CA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1387
引用
收藏
页码：1307 / 1308
页数：2
相关论文
共 50 条
  • [21] Evaluation of CD123 as a Potential Membrane Biomarker for Normal Karyotype Acute Myeloid Leukemia
    Jiang, Gina
    Pourabdollah, Maryam
    Atenafu, Eshetu
    Minden, Mark
    Chang, Hong
    LABORATORY INVESTIGATION, 2019, 99
  • [22] Prognostic impact of CD25, and CD123 expression in acute myeloid leukaemia patients
    Aref, S. E.
    Azmy, E. M.
    El Ghannam, M.
    Haroun, M. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 85 - 85
  • [23] Prognostic Significance of CD96 and CD123 in Adult Acute Myeloid Leukemia Patients in Egypt
    Hegab, Hany Mohamed Abdallah
    Ibrahim, Rasha Ibrahim
    Saeed, Alia Mohammed
    Abd Elmonem, Minerva Muhammad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S211 - S211
  • [24] CD123 redirected multiple virus-specific T cells for acute myeloid leukemia
    Zhou, Li
    Liu, Xin
    Wang, Xingbing
    Sun, Zimin
    Song, Xiao-Tong
    LEUKEMIA RESEARCH, 2016, 41 : 76 - 84
  • [25] New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells
    Du, Xing
    Ho, Mitchell
    Pastan, Ira
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (06) : 607 - 613
  • [26] BIFUNCTIONAL SIRPα-CD123 FUSION ANTIBODY FOR THE ELIMINATION OF ACUTE MYELOID LEUKEMIA STEM CELLS
    Tahk, S.
    Schmitt, S. M.
    Vick, B.
    Augsberger, C.
    Ponce, L. Pascual
    Jeremias, I.
    Wittmann, G.
    Subklewe, M.
    Fenn, N. C.
    Hopfner, K.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A58 - A58
  • [27] T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
    Mardiros, Armen
    Forman, Stephen J.
    Budde, Lihua E.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 484 - 488
  • [28] CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping
    Bras, Anne E.
    de Haas, Valerie
    van Stigt, Arthur
    Jongen-Lavrencic, Mojca
    Beverloo, H. Berna
    te Marvelde, Jeroen G.
    Zwaan, C. Michel
    van Dongen, Jacques J. M.
    Leusen, Jeanette H. W.
    van der Velden, Vincent H. J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (02) : 134 - 142
  • [29] CD123 Immunohistochemical Expression in Acute Myeloid Leukemia Is Associated with FLT3-ITD but Not NPM1 Mutations
    Rollins-Raval, M. A.
    Pillai, R. K.
    Djokic, M.
    Kant, J. A.
    Roth, C. G.
    LABORATORY INVESTIGATION, 2012, 92 : 365A - 365A
  • [30] CD123 Immunohistochemical Expression in Acute Myeloid Leukemia Is Associated with FLT3-ITD but Not NPM1 Mutations
    Rollins-Raval, M. A.
    Pillai, R. K.
    Djokic, M.
    Kant, J. A.
    Roth, C. G.
    MODERN PATHOLOGY, 2012, 25 : 365A - 365A
12345